Results The disruption of D2R-DAT stimulates locomotor activity As aforementioned, we developed an interfering peptide (TAT-DAT NT ) to disrupt the interaction between DAT and D2R, which can increase locomotor activity in mice [25]
coli BL21 strain, and captured with glutathione sepharose beads (GE Healthcare)
When CMS established C1831 as a new device category based on the approval of the aprevo (IFD) application for transitional pass-through payment status, there were no circumstances which warranted the use of vertebrae-specific language in the long descriptor, as such, none was included (87 FR 71894 and 71895)
A significant decrease ( p 0.01) was recorded in MDA level in MTX and HPE-treated group, compared with the MTX group, although this group was still recording a significant increase ( p 0.05) when compared with the control group
Combining nucleic acid chemical modifications with drug delivery systems is promising for better therapeutic outcomes